Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
CIBSS - Centre for Integrative Biological Signalling Studies, Albert-Ludwigs University, Freiburg, Germany.
Front Immunol. 2021 Apr 27;12:621503. doi: 10.3389/fimmu.2021.621503. eCollection 2021.
In common variable immunodeficiency (CVID), heterozygous damaging variants represent the most frequent monogenic cause. encodes the precursor p105, which undergoes proteasomal processing to generate the mature NF-κB transcription factor subunit p50. The majority of sequence changes comprises missense variants of uncertain significance (VUS), each requiring functional evaluation to assess causality, particularly in families with multiple affected members presenting with different phenotypes. In four affected members of a German family, all diagnosed with CVID, we identified a previously uncharacterized heterozygous missense variant (c.1049A>G; p.Tyr350Cys). The clinical phenotypes varied markedly regarding onset, frequency and severity of infections. Consistent immunologic findings were hypogammaglobulinemia with normal specific antibody response to protein- and polysaccharide-based vaccinations, reduced switched memory B cells and decreased lymphocyte proliferation upon stimulation with the B cell mitogen SAC. To assess the pathogenicity of the missense variant, we employed immunophenotyping and functional analyses in a routine cell culture model. Following site-directed mutagenesis to introduce the variant into overexpression vectors encoding EGFP-fused p105 or p50, we analyzed transiently transfected HEK293T cells by confocal imaging and Western blotting. The cytoplasmic p105-Tyr350Cys precursor gained only weak expression levels indicating accelerated decay. The missense change disabled processing of the precursor to prevent the generation of mutant p50. Unlike the wildtype p50, the overexpressed mutant p50-Tyr350Cys was also not sustainable and showed a conspicuous subnuclear mislocalization with accumulation in dense aggregates instead of a homogenous distribution. Electrophoretic mobility shift assays, fluorescence-based reporter gene analyses and co-transfection experiments however demonstrated, that the DNA-binding activity of p50-Tyr350Cys and the interaction with RelA(p65), IκBα and wildtype p50 were preserved. Mutation carriers had reduced p105 and p50 levels, indicating insufficient protein amounts as the most likely primary defect. In conclusion, the missense variant c.1049A>G caused a detrimental defect, preventing the persistent expression of both, the p105-Tyr350Cys precursor and the mature p50-Tyr350Cys. The variable clinical phenotypes among affected family members sharing an identical pathogenic variant support a disease mechanism provoked by a p105/p50 (haplo)insufficient condition.
在普通可变免疫缺陷症(CVID)中,杂合性有损伤的变异是最常见的单基因病因。 编码前体 p105,它经过蛋白酶体处理生成成熟的 NF-κB 转录因子亚基 p50。大多数 序列变化包括意义不明的错义变异(VUS),每个变异都需要进行功能评估以评估因果关系,特别是在有多个受影响成员的家族中,这些成员表现出不同的表型。在一个德国家族的四个受影响的成员中,所有成员均被诊断为 CVID,我们发现了一种以前未被描述的杂合性错义变异(c.1049A>G;p.Tyr350Cys)。临床表型在发病时间、感染频率和严重程度方面差异很大。一致的免疫发现是低丙种球蛋白血症,对蛋白和多糖疫苗有正常的特异性抗体反应,记忆 B 细胞转换减少,淋巴细胞增殖减少,对 B 细胞有丝分裂原 SAC 的刺激反应减少。为了评估 错义变异的致病性,我们在常规 细胞培养模型中进行了免疫表型分析和功能分析。在通过定点诱变将变异引入编码 EGFP 融合 p105 或 p50 的过表达载体后,我们通过共聚焦成像和 Western blot 分析瞬时转染的 HEK293T 细胞。具有 Tyr350Cys 取代的细胞质 p105-Tyr350Cys 前体仅表达微弱,表明其衰减加速。该错义变化使前体的加工失活,从而阻止了突变体 p50 的生成。与野生型 p50 不同,过表达的突变体 p50-Tyr350Cys 也不稳定,并且出现明显的亚核定位错误,聚集在致密的聚集体中,而不是均匀分布。电泳迁移率变动分析、基于荧光的报告基因分析和共转染实验表明,p50-Tyr350Cys 的 DNA 结合活性和与 RelA(p65)、IκBα 和野生型 p50 的相互作用得以保留。突变携带者的 p105 和 p50 水平降低,表明最有可能的原发性缺陷是蛋白质含量不足。总之,c.1049A>G 错义变异导致有害缺陷,阻止了 p105-Tyr350Cys 前体和成熟的 p50-Tyr350Cys 的持续表达。在具有相同致病性 变异的受影响家族成员中,不同的临床表型支持由 p105/p50(单倍体)不足引起的疾病机制。